In the field of immunotherapy, we also recommend new options according to specific targets in the cancer cells to make your Lymphocites recognize and sensitize them specific against your cancer cells.

We have several kinds of immune response cells in our bodies. But we focus on these 2 ones. Dendritic cells (that works as a presenting antigen to the immune cells).
And LAK or killer activated lymphocytes. (Those are the ones on charge of destroyed cancer cells).

In the new oncology treatments, there are many immune therapeutic approaches like monoclonal antibodies, check point inhibitors, and TK inhibitors. According to your tumor monoclonal diagnosis, we can also suggest adding some of these specific targeted therapies besides our protocols.